Bioinformatics Partnering Terms and Agreements @ http://www.researchmoz.us/bioinformatics-partnering-terms-and-agreements-report.html The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies.

1. Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and
unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading
healthcare companies.
Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering
contract documents Top deals by value Most active dealmakers Average deal terms for bioinformatics
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and
unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading
healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter bioinformatics
partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option
right tlicense the licensors bioinformatics technology. These deals tend tbe multicomponent, starting with
collaborative R&D, and commercialization of outcomes.
This report provides details of the latest bioinformatics agreements announced in the healthcare sectors.
Bioinformatics is the application of computer science and information technology tthe field of biology and
medicine. Bioinformatics deals with algorithms, databases, information systems, web technologies, artificial
intelligence, information and computation theory, software engineering, data mining, image processing,
modeling, simulation, signal processing, discrete mathematics, control systems, and statistics, for generating
new knowledge of biology and medicine.
Bioinformatics deals have increased in terms of popularity for partnering in the past decade, as computing
power has been embraced in order tspeed up the discovery, evaluation and clinical assessment processes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight
intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst
many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of
how payments are triggered – contract documents provide this insight where press releases and
databases dnot.
This report contains a comprehensive listing of all bioinformatics partnering deals announced since January
2007, including financial terms where available, including over 1700 links tonline deal records of actual
bioinformatics partnering deals as disclosed by the deal parties. In addition, where available, records include
contract documents as submitted tthe Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of bioinformatics dealmaking and business activities.
Chapter 1 provides an introduction tthe report, whilst
Chapter 2 provides an overview of the trends in bioinformatics dealmaking since 2007, including details of
average headline, upfront, milestone and royalty terms.
Chapter 3 provides a review of the leading bioinformatics deals since 2007. Deals are listed by headline
value, signed by bigpharma, most active big pharma and big biotech, and most active of all biopharma
companies. Where the deal has an agreement contract published at the SEC a link provides online access tthe
contract.
Bioinformatics Partnering Terms and Agreements

2. Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary
followed by a comprehensive listing of bioinformatics deals, as well as contract documents available in the
public domain. Where available, each deal title links via Weblink tan online version of the actual contract
document, providing easy access teach contract document on demand.
Chapter 5 provides a comprehensive listing of the top big biotech companies with a brief summary followed
by a comprehensive listing of bioinformatics deals, as well as contract documents available in the public
domain. Where available, each deal title links via Weblink tan online version of the actual contract document,
providing easy access teach contract document on demand.
Chapter 6 provides a comprehensive and detailed review of bioinformatics partnering deals signed and
announced since January 2007, where a contract document is available in the public domain. The chapter is
organized by stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and
specific therapy focus. Each deal title links via Weblink tan online version of the deal record and where
available, the contract document, providing easy access teach contract document on demand.
In addition, a comprehensive appendix is provided organized by bioinformatics partnering company A-Z ,
deal type definitions and bioinformatics partnering agreements example. Each deal title links via Weblink tan
online version of the deal record and where available, the contract document, providing easy access teach
contract document on demand.
The report alsincludes numerous tables and figures that illustrate the trends and activities in bioinformatics
partnering and dealmaking since 2007.
In conclusion, this report provides everything a prospective dealmaker needs tknow about partnering in the
research, development and commercialization of bioinformatics technologies and products.
Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits:
In-depth understanding of bioinformatics deal trends since 2007 Access theadline, upfront, milestone and
royalty data Analysis of the structure of bioinformatics agreements with numerous real life case studies
Comprehensive access tover 1700 bioinformatics deals entered intby the world’s biopharma
companies Detailed access tactual bioinformatics contracts enter intby the leading fifty bigpharma companies
Insight intthe terms included in a bioinformatics agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals Undertake due diligence tassess
suitability of your proposed deal terms for partner companies
Report scope
Bioinformatics Partnering Terms and Agreements is intended tprovide the reader with an in-depth
understanding and access tbioinformatics trends and structure of deals entered intby leading companies
worldwide.
Bioinformatics Partnering Terms and Agreements includes:
Trends in bioinformatics dealmaking in the biopharma industry since 2007 Analysis of bioinformatics deal
structure Access theadline, upfront, milestone and royalty data Case studies of real-life bioinformatics deals
Access tover 1700 bioinformatics deal documents Access tcontract documents where available The leading
bioinformatics deals by value since 2007 Most active bioinformatics dealmakers since 2007
The leading bioinformatics partnering resources In Bioinformatics Partnering Terms and Agreements, the
available contracts are listed by:
Company A-Z Headline value Stage of development at signing Deal component type Therapy target
Each deal title links via Weblink tan online version of the deal record and where available, the contract
document, providing easy access teach contract document on demand. The Bioinformatics Partnering Terms
Bioinformatics Partnering Terms and Agreements

3. and Agreements report provides comprehensive access tavailable deals and contract documents for over 1,500
bioinformatics deals. Analyzing actual contract agreements allows assessment of the following:
What are the precise bioinformatics rights granted or optioned? What is actually granted by the agreement
tthe partner company? What exclusivity is granted? What is the payment structure for the deal? How are sales
and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs
handled and owned? Whis responsible for commercialization? Whis responsible for development, supply, and
manufacture? How is confidentiality and publication managed? How are disputes tbe resolved? Under what
conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing
and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear tdiffer from partner tpartner or deal type tdeal type? Which jurisdiction does
the company insist upon for agreement law?
Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits:
In-depth understanding of bioinformatics deal trends since 2007 Access theadline, upfront, milestone and
royalty data Analysis of the structure of bioinformatics agreements with numerous real life case studies
Comprehensive access tover 1700 bioinformatics deal documents entered intby the world’s biopharma
companies Detailed access tactual bioinformatics contracts Provides insight intdeals dentered by top 50 big
pharma and top big biotech companies Insight intthe terms included in a bioinformatics agreement, together
with real world clause examples Understand the key deal terms companies have agreed in previous deals
Undertake due diligence tassess suitability of your proposed deal terms for partner companies
table Of Content
executive Summary
chapter 1 – Introduction
chapter 2 – Trends In Bioinformatics Dealmaking
2.1. Introduction
2.2. Bioinformatics Partnering Over The Years
2.3. Big Pharma Bioinformatics Dealmaking Activity
2.4. Big Biotech Bioinformatics Dealmaking Activity
2.5. Most Active Bioinformatics Dealmakers
2.6. Bioinformatics Partnering By Deal Type
2.7. Bioinformatics Partnering By Stage Of Development
2.8. Bioinformatics Partnering By Disease Type
2.9. Average Deal Terms For Bioinformatics Partnering
2.9.1 Bioinformatics Partnering Headline Values
2.9.2 Bioinformatics Deal Upfront Payments
2.9.3 Bioinformatics Deal Milestone Payments
2.9.4 Bioinformatics Royalty Rates
Bioinformatics Partnering Terms and Agreements

4. chapter 3 – Leading Bioinformatics Deals
3.1. Introduction
3.2. Top Bioinformatics Deals By Value
3.3. Top Bioinformatics Deals Involving Big Pharma
chapter 4 – Bigpharma Bioinformatics Deals
4.1. Introduction
4.2. How To Use Bigpharma Bioinformatics Partnering Deals
4.3. Big Pharma Bioinformatics Partnering Company Profiles
abbott
allergan
amgen
astellas
astrazeneca
baxter International
bayer
biogen Idec
boehringer Ingelheim
bristol-myers Squibb
csl
daiichi Sankyo
dainippon Sumitomo
eisai
eli Lilly
galderma
glaxosmithkline
grifols
hospira
johnson & Johnson
lundbeck
merck & Co
merck Kgaa
mitsubishi Tanabe
novartis
novo Nordisk
otsuka
pfizer
purdue
roche
sanofi
Bioinformatics Partnering Terms and Agreements

5. servier
shire
takeda
teva
ucb
valeant
chapter 5 – Bigbiotech Bioinformatics Deals
5.1. Introduction
5.2. How To Use Big Biotech Partnering Deals
5.3. Big Biotech Bioinformatics Partnering Company Profiles
array Biopharma
dendreon
elan
galapagos
genmab
grifols
ipsen
novo Nordisk
onyx Pharmaceuticals
spectrum Pharmaceuticals
vertex Pharmaceuticals
chapter 6 – Bioinformatics Dealmaking Directory With Contracts
6.1. Introduction
6.2. By Stage Of Development
discovery
formulation
marketed
phase Iii
6.3. By Deal Type
asset Purchase
bigpharma Outlicensing
collaborative R&d
co-market
contract Service
co-promotion
development
distribution
equity Purchase
licensing
Bioinformatics Partnering Terms and Agreements

6. litigation
manufacturing
marketing
option
promotion
research
settlement
sub-license
supply
termination
6.4. By Therapy Area
cardiovascular
hematology
hospital Care
infectives
oncology
chapter 7 – Bioinformatics Dealmaking By Technology Type
bioinformatics
software Tools
chapter 8 – Partnering Resource Center
8.1. Online Partnering
8.2. Partnering Events
8.3. Further Reading On Dealmaking
about Wildwood Ventures
current Partnering
current Agreements
recent Report Titles From Current Partnering
order Form – Reports
appendices
appendix 1: By Company A-z
appendix 2: By Stage Of Development
Bioinformatics Partnering Terms and Agreements

7. appendix 3: By Deal Type
appendix 4: By Therapy Area
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Bioinformatics Partnering Terms and Agreements